Orlando, FL July 2025 Plug and Play, the world-renowned global innovation platform, has announced the launch of its first-ever healthcare program in Orlando, Florida, in collaboration with Orlando Health, KPMG LLP, and GuideWell.
The program will officially debut on August 4, 2025, at the GuideWell Innovation Center in Lake Nona. Around 10 to 12 startups will be selected for the inaugural cohort, with applications now open via the Plug and Play website.
Driving Healthcare Innovation
The initiative aims to transform patient care by integrating cutting-edge technology into healthcare services. Selected startups will gain unique opportunities to showcase their innovations, connect with healthcare leaders, and collaborate with potential customers in need of advanced solutions.
Beyond improving healthcare delivery, the program is also expected to boost the local economy by attracting global startups, securing outside capital, and creating new jobs. This will further position Orlando as a leading hub for healthcare innovation.
Program Benefits for Startups
Participating startups will have access to a wealth of resources, including:
The program’s focus areas include enhancing patient care and advancing healthcare technologies.
Event Highlights
The launch event will feature:
These activities will create valuable connections between global innovators and local healthcare stakeholders.
Leadership Perspectives
Jake McGee, Director of Corporate Partnerships for Plug and Play Orlando, said:
“Plug and Play is thrilled to continue supporting startups in Orlando. By teaming up with three key leaders in the healthcare sector, we will develop and invest in the next generation of healthcare innovators.”
Pete Serio, VP and Chief Customer Officer at GuideWell, added:
“Our mission is to improve and transform the lives of the communities we serve. This partnership reflects our belief that collaboration in health innovation is the path to meaningful change. By connecting startups with strategic partners, we are creating synergy to deliver innovative solutions that can improve care, reduce costs, and drive better health outcomes.”
Request a customized case study tailored to your business needs and gain deeper insights into healthcare market strategies: sales@towardshealthcare.com
The global Leuprorelin drugs market was valued at US$ 2.60 billion in 2023 and is projected to reach US$ 4.78… Read More
The Factor Xa inhibitors market has witnessed substantial growth, with an estimated value of US$ 22.1 billion in 2023. This… Read More
North America is playing a pivotal role in the growth and development of the medical billing market. With its sophisticated… Read More
The global glycobiology market is poised for significant growth in the coming years. Valued at approximately USD 0.65 billion in… Read More
The insulin syringes market in the Asia-Pacific (APAC) region is expected to experience robust growth, with its market size projected… Read More
St. Louis, MO July 2025 MilliporeSigma, the U.S. life sciences division of Merck KGaA, Darmstadt, Germany, has entered into a… Read More